The role that JeanMarie Guenot has played towards the success of Amphivena Therapeutics

Jeanmarie Guenot has been working in the pharmaceutical and biotechnology industry for over two decades. She has worked with various stages of the company from the entry level to management. She has worked in the public sector, the private, commercial and corporate development, venture capital and many other sectors. Guenot is currently the Chief Executive Officer at Amphivena Therapeutics a company that has been looking for therapies that can successfully deal with hematologic malignancies.

Her journey to her current position started at Atlas Venture. She managed a number of venture capital investments and even helped in the building of companies that were connected with life science. The very first job that she held was being a principal scientist at Hoffman-La Roche. She was mandated with the task of discovering and developing drugs that treated metabolic disorders. Jeanmarie Guenot is a trained Doctor in the field of physical and medicinal chemistry. Other fields that she developed treatments for include autoimmune disease, inflammation and oncology. Her focus in school was quantum mechanical and semi-empirical methods for oncology and autoimmune diseases. Her MBA is from the Wharton School of the University of Pennsylvania while her PhD is from the University of California in San Francisco.

She has also worked at SKS Ocular. This is a company that deals with ophthalmic therapies. When she was there, she helped with the development of various illnesses related to glaucoma and macular degeneration. Guenot has also been involved as an advisor for Hoffman La-Roche. At Bio Pharma, she took care of the licensing, acquisition and the management of their commercial product portfolios on LinkedIn. Many cancer patients have benefited from the funds she has helped raise through mergers and acquisitions.

JeanMarie Guenot is a dedicated leader with a wealth of experience in the field. The values that she believes in include hard work, the ability to adapt to the changes that are happening in the world of technology and being responsive to the needs of the community in everything that one does. She is an inspirational scientist, business woman and advisor. In fact, she is a positive role model to many others like herself.

Read more: Maverick Therapeutics and Takeda Announce Five-year Collaboration to Advance T-Cell Engagement Therapies

Leave a Reply

Your email address will not be published. Required fields are marked *